EPIS, RAFFAELE
EPIS, RAFFAELE
Dipartimento di Bioscienze
Dynamic NFIX Promoter Usage Shapes Stem and Committed Myogenic States
2026 G. Rovetta, G. Ferrari, M. Ronzio, A. Gallo, R. Epis, C. Bonfanti, D. Dolfini, G. Careccia, G. Messina
Downstream Pathways of Dystrophin Deficiency in Duchenne Muscular Dystrophy: Implications for Muscle Degeneration and Regeneration
2026 R. Epis, G. Rovetta, G. Ferrari, C. Bonfanti, G. Careccia, G. Messina
PRECLINICAL EVALUATION OF A NOVEL NFIX INHIBITOR FOR MUSCULAR DYSTROPHIES TREATMENT
2025 R. Epis
Figuring out Nfix role in Cancer-Associated Cachexia: a novel player in Muscle Wasting
2025 G. Ferrari, C. Bonfanti, G. Rovetta, R. Epis, G. Messina, G. Careccia
Development of a high-throughput screening assay to identify Nfix-modulating drugs as a novel therapy for muscular dystrophy
2025 G. Rovetta, C. Monzani, G. Angelini, L. Bertazzoli, S. Di Savino, R. Epis, G. Careccia, G. Ferrari, C. Bonfanti, D. Dolfini, G. Messina
MEK-inhibitors decrease Nfix in muscular dystrophy but induce unexpected calcifications, partially rescued with Cyanidin diet
2024 G. Angelini, E. Capra, F. Rossi, G. Mura, M. Saclier, V. Taglietti, G. Rovetta, R. Epis, G. Careccia, C. Bonfanti, G. Messina